Position in INCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$337,359
New position
Shares Held
2,976
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#589
of 849 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Excelsior Advisor Network LLC holds $11,267,078 across 10 Biotechnology names. INCY ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IOVA |
Iovance Biotherapeutics, Inc.
|
1,783,924 | $7,421,123 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
30,385 | $1,669,351 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,060 | $526,533 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
626 | $390,336 | |
| 5 | INCY |
Incyte Corp
This page
|
2,976 | $337,359 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
17,975 | $261,895 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
6,327 | $246,816 | |
| 8 | ALLO |
Allogene Therapeutics, Inc.
|
95,991 | $199,661 |
All Filings in INCY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,359 | 2,976 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||